Charles River Laboratories International (NYSE:CRL) Given New $190.00 Price Target at Robert W. Baird
Charles River Laboratories International (NYSE:CRL – Free Report) had its price target decreased by Robert W. Baird from $191.00 to $190.00 in a research report released on Friday, Benzinga reports. Robert W. Baird currently has a neutral rating on the medical research company’s stock. Several other research analysts have also commented on the company. Argus […]
More Stories
How Career-Focused College Scholarships for Students Help Today’s Graduates Afford College and Hit the Workforce Job-Ready
College is a big investment, and students want more than a diploma. They want a fair price and a clear...
Trump Threatens to Target Iran’s Bridges, Power Plants on April 7 if Strait of Hormuz Not Reopened
By Jacki Thrapp U.S. President Donald Trump has threatened to target Iran’s power plants and bridges on April 7 if...
Iran Says It Will Retaliate If Civilian Infrastructure Is Targeted Amid Trump Deadline
By Jack Phillips Iranian officials on Sunday said the country would carry out more forceful attacks on targets if the...
Artemis II Day 4: Manual Flight in Deep Space, Lunar Flyby Preparations, Easter Message
By T.J. Muscaro HOUSTON—NASA astronaut Christina Koch and Canadian Space Agency astronaut Jeremy Hansen have become the first people in...
Mega Mergers Return to Food Industry in 1st Quarter Amid Pressure for Lower Prices
By Panos Mourdoukoutas The first quarter of 2026 marked a renewed wave of megamergers in the food industry, as companies...
California-Based Family Members of Qasem Soleimani Arrested, Green Cards Revoked
By Jacki Thrapp Two family members of assassinated Islamic Revolutionary Guard Corps Major General Qasem Soleimani were arrested by federal...